Cleared Traditional

K151746 - Dyevert Contrast Modulation System

K151746 is an FDA 510(k) clearance for Dyevert Contrast Modulation System, manufactured by Osprey Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DXT cleared through the Traditional 510(k) pathway after a 102-day FDA review.

K151746 · Osprey Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
102d
Days
Class 2
Risk

K151746 is an FDA 510(k) clearance for the Dyevert Contrast Modulation System. Classified as Injector And Syringe, Angiographic (product code DXT), Class II - Special Controls.

Submitted by Osprey Medical, Inc. (Minnetonka, US). The FDA issued a Cleared decision on October 9, 2015 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1650 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Osprey Medical, Inc. devices

FDA 510(k) Submission Details - K151746

510(k) Number K151746 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2015
Decision Date October 09, 2015
Days to Decision 102 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 125d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXT Device Classification - Class 2, Special Controls

Product Code DXT Injector And Syringe, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXT Injector And Syringe, Angiographic

All 164
Devices cleared under the same product code (DXT) and FDA review panel - the closest regulatory comparables to K151746.
Sterile High-pressure Angiographic Syringes for Single-use
K151960 · Shenzhen Baoan Medical Supplies Co., Ltd. · Jan 2016
330psi Extension Y-Line with Dual Check Valve
K150902 · Coeur, Inc. · Oct 2015
AVERT Contrast Modulation System
K151300 · Osprey Medical, Inc. · Oct 2015
AVERT Contrast Modulation System
K152218 · Osprey Medical · Sep 2015
MRXperion MR Injection System, MRXperion MR Injection System Syringe Kit
K143538 · Bayer Medical Care, Inc. · Aug 2015
125mL CT Syringe
K142745 · Coeur, Inc. · Apr 2015